Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.12963 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.87835 | 38 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.13695 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.09358 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.08241 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.12555 | 5 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.12629 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.05705 | 5 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.07977 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.16842 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.38773 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.12177 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.12756 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.09284 | 6 |